Driven to Deliver Innovative Treatments for Patients With Infectious Diseases

Nabriva is a clinical-stage biopharmaceutical company engaged in the research and development of novel antibiotics to treat serious infections, with a current focus on the pleuromutilin class of antibiotics.Learn More

FOR INVESTORS

CAREERS

Collaborate With Us

We’re developing innovative therapies that have the potential to transform the lives of people with infectious diseases, and our current platform is just the beginning. We actively seek collaborators and licensing opportunities focused on the discovery, development, and commercialization of technologies and therapies that address infectious diseases. Contact us to learn more.